Blauvelt, A., R. G. Langley, K. Peris, J. F. Silvestre, N. Katoh, M. Tauber, A. Pinter, M. Ameen, M. Gooderham, C. B. Øland, A.-M. Tindberg, L. Gjerum, and K. Reich. “Continuous Tralokinumab Treatment over 4 Years in Adults With Moderate-to-Severe Atopic Dermatitis Provides Long-Term Disease Control”. SKIN The Journal of Cutaneous Medicine, vol. 8, no. 2, Mar. 2024, p. s376, doi:10.25251/skin.8.supp.376.